Stripes

The transition arrived for Naomi Watts in her mid-thirties, far earlier than the cultural script allows, and what struck her most was the silence — no language, no products, no permission to talk about it. That isolation, more than any business plan, is the seed of the company. The name itself is a small act of defiance, borrowing the thread-like striping of chromosomes to frame midlife change as ordinary biology rather than a defect to hide.

The brand did not appear from nowhere. Watts had already co-founded a clean-beauty retailer, giving her a foothold in the industry before she built something for a demographic the industry ignored, and she launched the menopause line in partnership with the biotech and ingredients company Amyris. That alliance proved fragile: when Amyris filed for Chapter 11 bankruptcy, the young brand was swept toward the auction block and sold for a reported $500,000 to an entity with Watts listed as managing member, a near-death experience that reset everything.

The rescue brought professional muscle. The new ownership installed an executive chair who had run Revlon and a president drawn from L'Oréal, then pushed the catalog onto Amazon and television shopping and into Canada, expanding a range that deliberately spans the unglamorous full sweep of hormonal change — skincare, haircare, supplements, and intimate wellness — and wears its candor in cheeky product names. A sleep supplement blending melatonin, magnesium, and red clover signaled the move deeper into wellness beyond topicals.

The real contribution is cultural: dragging a stigmatized, underserved demographic into open conversation and treating it with empathy and humor instead of euphemism. The category caveat stands — these remain well-formulated cosmetics and supplements that can ease symptoms, not medical menopause treatment — but the candor it normalized is the genuine innovation here.

Sources:[1][2][3]